BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sukowati CH, El-Khobar KE, Ie SI, Anfuso B, Muljono DH, Tiribelli C. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. World J Gastroenterol 2016; 22(4): 1497-1512 [PMID: 26819517 DOI: 10.3748/wjg.v22.i4.1497] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Arora P, Basu A, Schmidt ML, Clark GJ, Donninger H, Nichols DB, Calvisi DF, Kaushik-Basu N. Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication. Hepatology 2017;65:1462-77. [PMID: 28090674 DOI: 10.1002/hep.29049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xie Y, Sun R, Gao L, Guan J, Wang J, Bell A, Zhu J, Zhang M, Xu M, Lu P, Cai X, Ren S, Xu P, Monga SP, Ma X, Yang D, Liu Y, Lu B, Xie W. Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma. Hepatol Commun 2022. [PMID: 34981658 DOI: 10.1002/hep4.1880] [Reference Citation Analysis]
3 Stern J, Miller G, Li X, Saxena D. Virome and bacteriome: two sides of the same coin. Curr Opin Virol 2019;37:37-43. [PMID: 31177014 DOI: 10.1016/j.coviro.2019.05.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
4 Zhen C, Zhu C, Chen H, Xiong Y, Tan J, Chen D, Li J. Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach. Oncotarget 2017;8:13909-16. [PMID: 28108733 DOI: 10.18632/oncotarget.14692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Chen J, Qian Z, Li F, Li J, Lu Y. Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma. Gut Liver 2017;11:112-20. [PMID: 27458175 DOI: 10.5009/gnl16063] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
6 Brito AF, Abrantes AM, Tralhão JG, Botelho MF. Targeting Hepatocellular Carcinoma: What did we Discover so Far? Oncol Rev 2016;10:302. [PMID: 27994769 DOI: 10.4081/oncol.2016.302] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
7 Ferro E, Visalli G, La Rosa MA, Piraino B, Civa R, Randazzo Papa G, Di Pietro A. Genotoxic effect of iron overload and disease complications in transfused β thalassaemic patients. MUTAGE. [DOI: 10.1093/mutage/gew062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Zhang W, Liu C, Tan Y, Jiang L, Yan L, Yang J, Wen T. Role of liver resection in treating intermediate and advanced stage adolescent and young adult hepatocellular carcinoma patients: A propensity-matching cohort study. International Journal of Surgery 2018;54:259-64. [DOI: 10.1016/j.ijsu.2018.03.051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Montenegro-Landívar MF, Tapia-Quirós P, Vecino X, Reig M, Valderrama C, Granados M, Cortina JL, Saurina J. Polyphenols and their potential role to fight viral diseases: An overview. Sci Total Environ 2021;801:149719. [PMID: 34438146 DOI: 10.1016/j.scitotenv.2021.149719] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen WC, Tseng CK, Chen BH, Lin CK, Lee JC. Grape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced Inflammation. Front Pharmacol 2016;7:490. [PMID: 28066241 DOI: 10.3389/fphar.2016.00490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Shao S, Sun J, Liu CY, Dong HJ, Li YQ, Gao YH. Aldehyde dehydrogenase 2 gene polymorphisms and liver diseases. Shijie Huaren Xiaohua Zazhi 2017; 25(33): 2981-2986 [DOI: 10.11569/wcjd.v25.i33.2981] [Reference Citation Analysis]
12 Xianyu J, Feng J, Yang Y, Tang J, Xie G, Fan L. Correlation of oxidative stress in patients with HBV-induced liver disease with HBV genotypes and drug resistance mutations. Clin Biochem. 2018;55:21-27. [PMID: 29596793 DOI: 10.1016/j.clinbiochem.2018.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
13 Topalian SL, Taube JM, Anders RA, Pardoll DM. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat Rev Cancer 2016;16:275-87. [PMID: 27079802 DOI: 10.1038/nrc.2016.36] [Cited by in Crossref: 1185] [Cited by in F6Publishing: 1154] [Article Influence: 197.5] [Reference Citation Analysis]
14 Maqbool T, Awan SJ, Malik S, Hadi F, Shehzadi S, Tariq K. In-Vitro Anti-Proliferative, Apoptotic and Antioxidative Activities of Medicinal Herb Kalonji (Nigella sativa). Curr Pharm Biotechnol 2019;20:1288-308. [PMID: 31433749 DOI: 10.2174/1389201020666190821144633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Mira C, Yepes JO, Henao LF, Montoya Guzmán M, Navas M. EXPRESIÓN DE LA PROTEÍNA CORE DEL VIRUS DE LA HEPATITIS C EN CÉLULAS HEPG2 USANDO EL VIRUS DEL BOSQUE DE SEMLIKI. Acta biol Colomb 2020;26:72-80. [DOI: 10.15446/abc.v26n1.79365] [Reference Citation Analysis]
16 Gupta H, Youn GS, Shin MJ, Suk KT. Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms. 2019;7:pii: E121. [PMID: 31060311 DOI: 10.3390/microorganisms7050121] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
17 Yu Y, He Z, Cao Y, Tang H, Huang F. TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication. Biochem Biophys Res Commun 2016;477:1051-8. [PMID: 27402267 DOI: 10.1016/j.bbrc.2016.07.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Mui UN, Haley CT, Tyring SK. Viral Oncology: Molecular Biology and Pathogenesis. J Clin Med 2017;6:E111. [PMID: 29186062 DOI: 10.3390/jcm6120111] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
19 Galli A, Munnia A, Cellai F, Tarocchi M, Ceni E, van Schooten FJ, Godschalk R, Giese RW, Peluso M. Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients. Int J Mol Sci 2020;21:E6753. [PMID: 32942546 DOI: 10.3390/ijms21186753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Xu Q, Gu S, Liang J, Lin Z, Zheng S, Yan J. The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma. Oncol Res 2019;27:509-14. [PMID: 29891022 DOI: 10.3727/096504018X15278771272963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Schulte LA, López-Gil JC, Sainz B Jr, Hermann PC. The Cancer Stem Cell in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E684. [PMID: 32183251 DOI: 10.3390/cancers12030684] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
22 Huang W, Zhou W, Li C, Yang Y, Shang YK, Chen C, Zhang J, Yao R, Wang P, Wen W, Liu HQ, Wang L, Li X, Bian H, Chen ZN. Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma. Oncotarget 2017;8:26288-97. [PMID: 28460432 DOI: 10.18632/oncotarget.15458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nankya-Mutyoba J, Aizire J, Makumbi F, Ocama P, Kirk GD. Hepatitis B virus perceptions and health seeking behaviors among pregnant women in Uganda: implications for prevention and policy. BMC Health Serv Res 2019;19:760. [PMID: 31655575 DOI: 10.1186/s12913-019-4516-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 N Zekri AR, Salama H, Medhat E, Hamdy S, Hassan ZK, Bakr YM, Youssef AS-D, Saleh D, Saeed R, Omran D. Potential Diagnostic and Prognostic Value of Lymphocytic Mitochondrial DNA Deletion in Relation to Folic Acid Status in HCV-Related Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2017;18:2451-7. [PMID: 28952275 DOI: 10.22034/APJCP.2017.18.9.2451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Camini FC, da Silva Caetano CC, Almeida LT, de Brito Magalhães CL. Implications of oxidative stress on viral pathogenesis. Arch Virol 2017;162:907-17. [PMID: 28039563 DOI: 10.1007/s00705-016-3187-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 12.2] [Reference Citation Analysis]
26 Lee SH, Park JW, Woo SH, Go DM, Kwon HJ, Jang JJ, Kim DY. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice. Oncotarget 2016;7:87219-31. [PMID: 27888617 DOI: 10.18632/oncotarget.13529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
27 Kang DS, Yang JH, Kim HS, Koo BK, Lee CM, Ahn YS, Jung JH, Seo YR. Application of the Adverse Outcome Pathway Framework to Risk Assessment for Predicting Carcinogenicity of Chemicals. J Cancer Prev 2018;23:126-33. [PMID: 30370257 DOI: 10.15430/JCP.2018.23.3.126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Łapiński TW, Tarasik A, Januszkiewicz M, Flisiak R. Clinical aspects and treatment of hepatocellular carcinoma in north-eastern Poland. Clin Exp Hepatol 2021;7:79-84. [PMID: 34027119 DOI: 10.5114/ceh.2021.104631] [Reference Citation Analysis]
29 Hu B, Wang R, Fu J, Su M, Du M, Liu Y, Li H, Wang H, Lu F, Jiang J. Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy. J Gastroenterol Hepatol 2018;33:1389-96. [PMID: 29266382 DOI: 10.1111/jgh.14075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
30 De Mattia E, Cecchin E, Polesel J, Bignucolo A, Roncato R, Lupo F, Crovatto M, Buonadonna A, Tiribelli C, Toffoli G. Genetic biomarkers for hepatocellular cancer risk in a caucasian population. World J Gastroenterol 2017; 23(36): 6674-6684 [PMID: 29085212 DOI: 10.3748/wjg.v23.i36.6674] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
31 Kaur H, Bhalla S, Raghava GPS. Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles. PLoS One 2019;14:e0221476. [PMID: 31490960 DOI: 10.1371/journal.pone.0221476] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
32 De Mattia E, Cecchin E, Polesel J, Lupo F, Tiribelli C, Crovatto M, Buonadonna A, Toffoli G. UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population. Liver Int. 2017;37:1345-1353. [PMID: 28294511 DOI: 10.1111/liv.13411] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
33 Van Hees S, Michielsen P, Vanwolleghem T. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2016; 22(37): 8271-8282 [PMID: 27729734 DOI: 10.3748/wjg.v22.i37.8271] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
34 Mohamed AA, Abo-elmatty DM, ezzat OI, Youssef AA, Mehanna ET, Hassnine AA, Mesbah NM, Saed S, Sayed EA, Hamada M, Khamis AF, Elshentenawy A, Abd El-raouf MS, Abd-elsalam S, Elsayed AM. Expression of a Disintegrin and Metalloprotease 10 Gene Polymorphisms in a Cohort of Egyptian Patients with Hepatocellular Carcinoma. CCTR 2021;17:312-8. [DOI: 10.2174/1573394717666210427122703] [Reference Citation Analysis]
35 Moore MM, Schoeny RS, Becker RA, White K, Pottenger LH. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Crit Rev Toxicol 2018;48:312-37. [PMID: 29431554 DOI: 10.1080/10408444.2017.1423462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]